Advances in Drug Safety Surveillance Infrastructure in the US FDA Sentinel Read more about Advances in Drug Safety Surveillance Infrastructure in the US FDA Sentinel
Improving the Identification of Pregnancies in Claims Data: A Descriptive Analysis Read more about Improving the Identification of Pregnancies in Claims Data: A Descriptive Analysis
Characterization of Confounding Covariates in the Sentinel Distributed Database (SDD): A Descriptive Analysis Read more about Characterization of Confounding Covariates in the Sentinel Distributed Database (SDD): A Descriptive Analysis
Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) & Signal Identification Read more about Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide)
Proportion of Incident Syndrome of Inappropriate Antidiuretic Hormone Secretion Cases with Evidence of Pulmonary Opportunistic Infections Among New Users of BIC/FTC/TAF: A Descriptive Analysis Read more about Proportion of Incident Syndrome of Inappropriate Antidiuretic Hormone Secretion Cases with Evidence of Pulmonary Opportunistic Infections Among New Users of BIC/FTC/TAF: A Descriptive Analysis
Outcome Monitoring Following Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Use: A Self-Controlled Risk Interval Signal Identification Analysis Read more about Outcome Monitoring Following Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Use: A Self-Controlled Risk Interval Signal Identification Analysis
Insights on Harmonizing Laboratory Results Data in the Sentinel System Read more about Insights on Harmonizing Laboratory Results Data in the Sentinel System
Utilization of Type 2 Diabetes Mellitus Products in the Sentinel Distributed Database, 2008-2024 Read more about Utilization of Type 2 Diabetes Mellitus Products in the Sentinel Distributed Database, 2008-2024
Utilization of Hormonal Contraceptives During the Postpartum Period in the FDA Sentinel System Read more about Utilization of Hormonal Contraceptives During the Postpartum Period in the FDA Sentinel System